Literature DB >> 9058401

Menstruation, sex hormones, and migraine.

E A MacGregor1.   

Abstract

All women with migraine are susceptible to the effects of hormonal changes. For a minority with menstrual migraine, fluctuating hormones of the normal ovarian cycle are a specific trigger, particularly during perimenopause. The author proposes that the term menstrual migraine should be restricted to migraine attacks occurring on day 1 +/- 2 days of the menstrual cycle with freedom from migraine during the rest of the cycle. This definition is compatible with the mechanism of estrogen withdrawal. Other mechanisms such as prostaglandin release also may be important for some women. The changing hormonal environment at various stages of life provides further evidence of the role of estrogen in migraine. Treatments that stabilize hormone levels in the form of estrogen supplementation for menstrual migraine, elimination of the pill-free week, and adequate, stable levels of estrogen for HRT, all are associated with an improvement in migraine. The control of the menstrual cycle, however, is extremely complex, and until further studies are undertaken using strict criteria, the mechanism of migraine triggered by hormonal events remains uncertain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9058401     DOI: 10.1016/s0733-8619(05)70299-1

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  19 in total

1.  Migraine prophylaxis in adult patients.

Authors:  D Parsekyan
Journal:  West J Med       Date:  2000-11

Review 2.  Headache.

Authors:  T J Steiner; Manuela Fontebasso
Journal:  BMJ       Date:  2002-10-19

Review 3.  Nonpharmacologic treatment of migraine.

Authors:  Peter S Sándor; Judit Afra
Journal:  Curr Pain Headache Rep       Date:  2005-06

Review 4.  Long-term impact of neonatal injury in male and female rats: Sex differences, mechanisms and clinical implications.

Authors:  Jamie L LaPrairie; Anne Z Murphy
Journal:  Front Neuroendocrinol       Date:  2010-02-06       Impact factor: 8.606

Review 5.  Brain-derived neurotrophic factor-estrogen interactions in the hippocampal mossy fiber pathway: implications for normal brain function and disease.

Authors:  L C Harte-Hargrove; N J Maclusky; H E Scharfman
Journal:  Neuroscience       Date:  2012-12-29       Impact factor: 3.590

Review 6.  Menstrual migraine: diagnosis and treatment.

Authors:  C L Lay; A M Mascellino
Journal:  Curr Pain Headache Rep       Date:  2001-04

7.  Progesterone receptor gene (PROGINS) polymorphism correlates with late onset of migraine.

Authors:  Raffaele Palmirotta; Piero Barbanti; Cristiano Ialongo; Maria Laura De Marchis; Jhessica Alessandroni; Gabriella Egeo; Cinzia Aurilia; Luisa Fofi; Maria Giovanna Valente; Patrizia Ferroni; David Della-Morte; Fiorella Guadagni
Journal:  DNA Cell Biol       Date:  2014-12-10       Impact factor: 3.311

8.  Hereditary patterns of Belgrade university female students with migraine and nonmigraine primary headache.

Authors:  Hristina D Vlajinac; Eleonora D Dzoljic; Sandra B Sipetic; Vlada S Kostic
Journal:  J Neurol       Date:  2004-08       Impact factor: 4.849

Review 9.  Menstrual migraine: a review of prophylactic therapies.

Authors:  Vincent T Martin
Journal:  Curr Pain Headache Rep       Date:  2004-06

10.  The estrogen receptor 1 G594A polymorphism is associated with migraine susceptibility in two independent case/control groups.

Authors:  Natalie J Colson; Rod A Lea; Sharon Quinlan; John MacMillan; Lyn R Griffiths
Journal:  Neurogenetics       Date:  2004-05-07       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.